Found: 2
Select item for more details and to access through your institution.
ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The μ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy.
- Published in:
- Journal of Pain Research, 2019, v. 12, p. 3113, doi. 10.2147/JPR.S217563
- By:
- Publication type:
- Article
Electrophoretic Plasma Protein Patterns in Families with Hemophilia.∗.
- Published in:
- Proceedings of the Society for Experimental Biology & Medicine, 1953, v. 83, n. 2, p. 311, doi. 10.3181/00379727-83-20343
- By:
- Publication type:
- Article